Integrative & Lifestyle Treatment Options

masthead_ph_shadows_9

Events

Integrative & Lifestyle Treatment Options

llc_header

Events Presentations

CLL Education Event- Montreal, QC

News Research

Health Canada Approves GAZYVA® for Patients with Previously Treated Follicular Lymphoma

News

BCCA Provincial Systemic Therapy Program approves new program

Events

Southwestern Ontario Chapter Peer-to-Peer Support Meeting

masthead_ph_shadows

News Research

pCODR Final Recommendation Issued for idelalisib (Zydelig) for Follicular Lymphoma

masthead_ph_rocks

News Research

pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Waldenstrom’s Macroglobulinemia

News Research

pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for First-line Treatment of CLL

masthead_ph_largeleaves

News Research

pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL)

masthead_ph_largeleaves

News Research

Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available

Join Our Mailing List

© 2025 Lymphoma Canada.